CRISPR Therapeutics AG

NASDAQ: CRSP
$53.10
-$0.80 (-1.5%)
Closing Price on July 5, 2024

CRSP Chart and Intraday Price

CRSP Company Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address BAARERSTRASSE 14, ZUG, CH
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 6,723.12M USD
Shares Outstanding 80,276,000
CRISPR Therapeutics AG is at the forefront of gene editing, pioneering treatments for serious diseases through its CRISPR/Cas9 technology. This innovative approach allows for precise DNA modifications, offering hope in areas like hemoglobinopathies, immune-oncology, autoimmune diseases, and type 1 diabetes. Its leading therapy, CASGEVY, aims to transform care for patients with severe blood disorders through gene-edited cell therapy. Additionally, the company is developing cutting-edge CAR T cell therapies and in vivo gene editing solutions, working in strategic partnerships to advance its mission of curing complex diseases.

CRSP Articles

Forget Intuitive Surgical: This Stock Is the Next Millionaire Maker
Imagine this: you walk into a hospital for a procedure. You expect a long, traditional surgery with a lengthy recovery. But what if, instead of the scalpel, you could invest in a company with the...
Kristin Hitchcock
Published:

CEO Dumps 20 Million Ginkgo Bioworks Shares
Why did Ginkgo Bioworks CEO Jason Kelly chop 20 million shares from his stake in the company? Is no turnaround for the shares coming?
Trey Thoelcke
Published:

Wednesday's Top Analyst Upgrades and Downgrades: Abbott Labs, Boston Scientific, ChargePoint, Coinbase, Dollar General, Equitrans, Ford, Hasbro, Johnson & Johnson, Kenvue, Medtronic and More
Wednesday's top analyst upgrades and downgrades included Abbott Laboratories, Boston Scientific, ChargePoint, Coinbase Global, Dollar General, Equitrans Midstream, Ford, Hasbro, Johnson & Johnson,...
Lee Jackson
Published:

Friday's Top Analyst Upgrades and Downgrades: American Airlines, Broadcom, Chevron, DraftKings, Exxon Mobil, Hertz, McDonald's, Merck, Meta, Shopify and More
Friday's top analyst upgrades and downgrades included American Airlines, Broadcom, Chevron, DraftKings, Enphase Energy, EOG Resources, Exxon Mobil, First Solar, Hertz Global, LyondellBasell...
Lee Jackson
Published:

Barclays Picks 2 Winners and 2 Losers After Earnings
Barclays recently issued a few calls across multiple industries picking a couple winners and a couple losers.
Chris Lange
Published:

Are Earnings Actually Priced In? Analysts Upgrade or Downgrade Nike, Palantir and More
Tuesday's additional top analyst upgrades and downgrades were on Bed Bath & Beyond, Clorox, CRISPR Therapeutics, LivePerson, Nike, Palantir Technologies, Tyson Foods and more.
Chris Lange
Published:

Will CRISPR Stock Double in the Next Year?
One big Wall Street name thinks it has found a big winner in this gene-editing company, and the stock could benefit greatly going forward.
Chris Lange
Published:

The Fed to the Rescue? Analysts Upgrade or Downgrade American Tower, Coinbase, Snowflake, Southwest and More
Thursday's additional top analyst upgrades and downgrades included American Tower, Coinbase, Snowflake, Southwest and more.
Chris Lange
Published:

Wednesday's Top Analyst Upgrades and Downgrades: eBay, EOG, Etsy, Global Payments, JPMorgan, MetLife, Otis, Salesforce, Wayfair and More
Wednesday's top analyst upgrades and downgrades included Albemarle, Camping World, eBay, EOG Resources, Etsy, Global Payments, IMAX, JPMorgan Chase, MetLife, Otis Worldwide, Salesforce, Wayfair and...
Lee Jackson
Published:

Thursday's Top Analyst Upgrades and Downgrades: Boeing, Capital One, Coinbase, Electronic Arts, Harley-Davidson, Peloton, Walmart, Wynn Resorts and More
Thursday's top analyst upgrades and downgrades included Alcon, Array Technologies, AZEK, Boeing, Capital One Financial, Coinbase Global, Corning, Electronic Arts, Harley-Davidson, ON Semiconductor,...
Lee Jackson
Published:

Thursday's Top Analyst Upgrades and Downgrades: Airbnb, Alcoa, Beyond Meat, Marriott, Monster Beverage, Paramount, Shopify, Toast, ZoomInfo and More
Thursday's top analyst upgrades and downgrades included Airbnb, Alcoa, Beyond Meat, Fidelity National Information Services, Marriott International, Monster Beverage, Paramount Global, Shopify, Spirit...
Lee Jackson
Published:

5 Sizzling 'Strong Buy' Analyst Biotechnology Picks for 2022
Biotechnology was a huge laggard last year, but Truist Securities is out with its five top picks for 2022 that could see some sensational performance this year. Portfolio managers favor these...
Lee Jackson
Published:

Cathie Wood's ARK Invest Buys Nearly 60,000 Shares of CRISPR
A couple of Cathie Wood's ARK Invest exchange-traded funds bought nearly 60,000 shares of CRISPR Therapeutics on December 29 for $4.6 million.
Chris Lange
Published:

Tuesday Afternoon's Analyst Upgrades and Downgrades: Alibaba, Apple, Canopy Growth, Tesla and More
Tuesday afternoon's top analyst upgrades and downgrades included Alibaba, Apple, AstraZeneca, Canopy Growth, CNX Resources, Murphy Oil, Ross Stores and Tesla.
Chris Lange
Published:

Tuesday Afternoon Analyst Upgrades and Downgrades: CRISPR, Editas, Esperion Therapeutics, Marriott Penn National Gaming and More
Tuesday afternoon's analyst upgrades and downgrades included CRISPR, Editas, Esperion Therapeutics, Marriott Penn National Gaming and more.
Chris Lange
Published: